These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35961786)

  • 21. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China.
    Yang W; Yang S; Wang L; Zhou Y; Xin Y; Li H; Mu W; Wu Q; Xu L; Zhao M; Wang C; Yu K
    Virol Sin; 2022 Oct; 37(5):704-715. PubMed ID: 35948265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature.
    Fernández-de-Las-Peñas C; Notarte KI; Peligro PJ; Velasco JV; Ocampo MJ; Henry BM; Arendt-Nielsen L; Torres-Macho J; Plaza-Manzano G
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; AlMukdad S; Yassine HM; Al-Khatib HA; Smatti MK; Tang P; Hasan MR; Coyle P; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R
    N Engl J Med; 2022 May; 386(19):1804-1816. PubMed ID: 35263534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.
    Wu Y; Guo Z; Yuan J; Cao G; Wang Y; Gao P; Liu J; Liu M
    Int J Infect Dis; 2023 Apr; 129():228-235. PubMed ID: 36804640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study.
    Wei Z; Ma W; Wang Z; Li J; Fu X; Chang H; Qiu Y; Tian H; Zhu Y; Xia A; Wu Q; Liu G; Zhai X; Zhang X; Wang Y; Zeng M
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13097. PubMed ID: 36843225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.
    Kang W; Yang P; Dang B; Zhang W; Gang Y; Wang W; Ma C; Zhao Y; Zhang Y; Hao C; Quan H; Li J; Cao J; Kang W; Shang L
    Int J Infect Dis; 2023 May; 130():60-70. PubMed ID: 36849069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
    JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
    He X; Su J; Ma Y; Zhang W; Tang S
    Front Immunol; 2022; 13():945930. PubMed ID: 36090988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis.
    Wang B; Andraweera P; Elliott S; Mohammed H; Lassi Z; Twigger A; Borgas C; Gunasekera S; Ladhani S; Marshall HS
    Pediatr Infect Dis J; 2023 Mar; 42(3):232-239. PubMed ID: 36730054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.
    Butt AA; Dargham SR; Tang P; Chemaitelly H; Hasan MR; Coyle PV; Kaleeckal AH; Latif AN; Loka S; Shaik RM; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Glob Health; 2022 Jul; 12():05032. PubMed ID: 35788085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
    Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
    [No Abstract]   [Full Text] [Related]  

  • 37. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis.
    Alene M; Yismaw L; Assemie MA; Ketema DB; Mengist B; Kassie B; Birhan TY
    PLoS One; 2021; 16(3):e0249090. PubMed ID: 33755688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
    Chun JY; Jeong H; Kim Y
    BMC Med; 2022 Nov; 20(1):451. PubMed ID: 36419108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.